OP0595

· Meiji Seika Pharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OP0595, covering 2014-12-12 to 2014-12-12. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study to Assess Safety, Tolerability and Pharmacokinetics of OP0595 [Phase 1]